CERN Stock Price - Cerner Corp - (CERN)
- Prev. Close: 72.78
- Open: 72.43
- Daily Range: 72.02 - 72.75
CERN NEWS FROM BIDNESS ETC
Cerner Corporation Down On Earnings Miss
Cerner's shares fell today as the company posted mixed earnings results for the third quarter of fiscal'14 yesterday and issued a soft guidance for th...
Gilead Sciences, Inc. Continues To Lead The Hepatitis C Market; Its HCV Dru...
Gilead continues to be the undisputed leader of the hepatitis C space, with almost 11,000 prescriptions for its drugs compared to 1,739 prescriptions ...
Here’s Why PTC Therapeutics, Inc. (PTCT) Plunged During Friday’s Tradin...
PTC Therapeutics, a maker of drugs for rare diseases, reported a net loss of $27.3 million for the fourth quarter of fiscal 2014
- Doral Financial Corp. (DRL) Shut Down In Puerto Rico
- What Pivotal Research Has To Say About Herbalife Ltd.
- Are Insiders Losing Trust In GoPro Inc (GPRO)?
- Credit Suisse Group (NYSE:CS) Reduces 4Q Profit, Lifts Legal Provisions
- T-Mobile CEO Feels Partnering With Dish “Makes Sense”
- Verizon Communications Inc. Complains About DISH Network Corp Bid Tactics; ...
- Will Tesla Motors Inc Gigafactory Start Producing Batteries As Early As Nex...
- Under Armour Inc (UA) Signs The Flying Dutchman, Memphis Depay
- Facebook Inc Collects Demographic Data Ahead Of F8 Conference
More News From Bidness
Sprint Corp (S) Stock Rises 7.3% Following CEO’s Purc... PUBLISHED: Feb 28, 2015 at 10:14 am ESTIs Rio Tinto plc (ADR) Headed Toward A Coal Exit? PUBLISHED: Feb 28, 2015 at 10:03 am ESTInsider Selling: FireEye Inc, T-Mobile US Inc, CBS Corp... PUBLISHED: Feb 28, 2015 at 10:00 am ESTT-Mobile US Inc Un-Carrier Moves May Soon Hit Small Bus... PUBLISHED: Feb 28, 2015 at 9:54 am EST
Novartis AG (ADR) Lung Cancer Drug Wins EU Recommendation PUBLISHED: Feb 28, 2015 at 9:34 am EST
Gilead Sciences, Inc. HIV Drug TAF Could Replace Current Standard Treatment Viread PUBLISHED: Feb 28, 2015 at 9:34 am EST
Gilead’s TAF-based HIV regimen may eventually replace the company’s current HIV treatment Viread, after the new drug proved to be safer for use in a late-stage studyREAD MORE
Under Armour Inc Plans To Venture Into Electronic Apparel PUBLISHED: Feb 28, 2015 at 9:24 am EST
Under Armour has been spending heavily on acquiring developers for fitness-monitoring apps, as it looks to enter the electronic apparel spaceREAD MORE
Sprint Corp Collaborates With Best Buy Co Inc For An All-Inclusive Plan PUBLISHED: Feb 28, 2015 at 9:14 am EST
The Best Buy One Plan offers unlimited talk time, text, and data. It also includes the option of leasing a device on the carrierREAD MORE
QUALCOMM, Inc. (QCOM) Leads 3D Robotics’ Latest Funding Spree Of $50 Million PUBLISHED: Feb 28, 2015 at 8:54 am EST
3D Robotics, which has made a big name for itself in the consumer drone industry, plans to utilize the funding to reach sales of $50 millionREAD MORE
MannKind Corporation Afrezza Takes Off; RBC Recommends A Buy PUBLISHED: Feb 28, 2015 at 8:49 am EST
Royal Bank of Canada reiterated its Buy rating on MannKind, following the launch of the company’s inhalable insulin AfrezzaREAD MORE